IIM
STLN

INTECH Investment Management’s Starling Oncology STLN Stock Holding History

INTECH Investment Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
20,531
-1,951
-9% -$8.2K ﹤0.01% 1928
2026
Q1 		$69K Buy
22,482
+4,760
+27% +$14.6K ﹤0.01% 1964
2025
Q4 		$63.1K Sell
17,722
-1,887
-10% -$7K ﹤0.01% 2238
2025
Q3 		$68.4K Sell
19,609
-9,005
-31% -$30.9K ﹤0.01% 2338
2025
Q2 		$58.7K Buy
+28,614
New +$71.5K ﹤0.01% 2402

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

INTECH Investment Management's STLN Position: Q2 2026 in Review

INTECH Investment Management reduced its Starling Oncology (STLN) stake by 8.7% in Q2 2026, selling an estimated $8.2K and leaving 20,531 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

INTECH Investment Management first reported a position in STLN in Q2 2025 and has held it in 5 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • INTECH Investment Management held 20,531 shares of Starling Oncology worth $111K as of Q2 2026.
  • INTECH Investment Management sold 1,951 Starling Oncology shares in Q2 2026, an estimated $8.2K.
  • Starling Oncology made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1928 holding.
  • INTECH Investment Management first reported a position in Starling Oncology in Q2 2025 and has held it in 5 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.